Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
Muddled Carrot
FFS, you really are very tiresome. Read my post carefully.
I repeat, and nothing more should or can be read into this, it is a fact.
It remains the case that improvements in analysis of ctDNA are not of benefit directly to AGL and the Parsortix system.
Muddled Carrot
Oh dear. I have read - and understood - Jan 4th RNS, with its cobbled together spin on in-house, unrefereed, and unpublished data. many times.
It remains the case that improvements in analysis of ctDNA are not of benefit directly to AGL and the Parsortix system. Parsortix may have a role when used in combination with ctDNA, although I think AGL is probably hanging onto the coat tails of ctDNA here.
I await Friday with interest.
Carrot
You always leave out an important point:
Angle's Parsortix machine can catch the circulating tumour cells in the patient’s blood from a STANDARD BLOOD SAMPLE ---and then the DNA can be tested---If CTCs are present.
Can someone remind me about the kiln please. I thought that - way back - the kiln / combustion chamber was to be lined with ceramic tiles.Is that still the case, or is PHE relying on a super special alloy resistant to noxious gases at high temperatures?
I might settle for £25
Carrot
Make up your mind.
"Moab, at least looking at one of his/her posts back in Jan this year claims to be a long-term holder and probably is."
I do not regard someone who invested (what skill!) in November 2023 as an LTH. Try 2020.
Researcher 1, re yours of 17th May
I have no agenda, paranoia not helpful here. If a blood sample is spiked with a malignant cell, Parsortix will capture it, a doddle akin to shooting animals in a zoo. but as I and others have repeatedly pointed out, from a population of patients with metastatic malignancy, it is not possible to capture malignant cells from a single blood sample on 100% of patients; some will simply not have circulating tumour cells to capture at the time of sampling.
No agenda, just fact.
Carrot
Let other posters be clear. 99% of Parsortix tumour cells captured may be alive, but be under no illusion that Parsortix captures CTCs in every case of cancer, even where metastatic spread is evident. It simply does not, and that limits the value of the technique.
This is not de-ramping, as you would have it, but an ineluctable fact.
Carrot
I report facts only. Once. I have no need to comment on anyone else's posts apart from yours, for often stated reasons that I cannot be bothered to repeat. Jealous of you? I think not
Keep ramping.
Carrot
I am proud to be included in your comments. I have only at any time written verifiable facts on this board. In English, without idiotic stars, exclamation marks, capitals, etc,. and all the other childish rubbish that is repeated endlessly and which readers find so irritating. As a ramper you have so much to learn.